Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis | Journal of Patient-Reported Outcomes | Full Text
Measurement Properties of PROMIS Sleep Disturbance Short Forms in a Large, Ethnically Diverse Cancer Cohort | Semantic Scholar
SLEEP DISTURBANCE
SLEEP-RELATED IMPAIRMENT
An Overview of the Patientâ•'Reported Outcomes Measurement Information System (PROMIS) for Assessing Chronic Low Back Pain
PROMIS-Sleep Disturbance | RehabMeasures Database
Measurement Properties of PROMIS Sleep Disturbance Short Forms in a Large, Ethnically Diverse Cancer Cohort | Semantic Scholar
Understanding Sleep Problems with the Conners 4™ and PROMIS® Sleep Measures
Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS Sleep Disturbance and Sleep-Related Impairment measures for assessment of VMS impact on sleep. - Abstract - Europe PMC
Measurement Properties of PROMIS Sleep Disturbance Short Forms in a Large, Ethnically Diverse Cancer Cohort | Semantic Scholar
PROMIS SCORING GUIDE
Abnormal Psychology - APA DSM5 Level-2-Sleep-Disturbance-Adult - The APA is offering a number of - Studocu
Open Access) PROMIS 4-item measures and numeric rating scales efficiently assess SPADE symptoms compared with legacy measures. (2019) | Kurt Kroenke | 14 Citations
BRICS NINR PROMIS SF v1.0-Sleep Disturbance 6a
Measurement Properties of PROMIS Sleep Disturbance Short Forms in a Large, Ethnically Diverse Cancer Cohort | Semantic Scholar
Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. - Abstract - Europe PMC
Development and validation of an interpretive guide for PROMIS scores | Journal of Patient-Reported Outcomes | Full Text
Figure 1 from Improving sleep-wake disturbances in patients with cancer. | Semantic Scholar
Frontiers | Test–Retest Reliability and Responsiveness of PROMIS Sleep Short Forms Within an RCT in Women With Fibromyalgia
PDF) Development of Short Forms from the PROMIS Sleep Disturbance and Sleep-Related Impairment Item Banks
Validation of the PROMIS-29 Profile in Patients with Active Psoriatic Arthritis Using Data from a Phase 3, Randomized, Placebo-Controlled Study Evaluating Guselkumab (TREMFYA®) - ACR Meeting Abstracts
Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy - Journal of the American Academy of
Please respond to each item by checking one box per row
